Kristina H Jackson1, William S Harris2,3. 1. OmegaQuant, LLC, 5009 W. 12th St., Suite 8, Sioux Falls, SD, 57106, USA. kristina@omegaquant.com. 2. OmegaQuant, LLC, 5009 W. 12th St., Suite 8, Sioux Falls, SD, 57106, USA. 3. Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA.
Abstract
PURPOSE OF REVIEW: Fatty acid (FA) profiles in different blood compartments are reflections of both diet and metabolism, and some FA levels are related to disease risk. RECENT FINDINGS: Perhaps the most studied FA-disease relationship is between long-chain omega-3 polyunsaturated fatty acids [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] and cardiovascular disease (CVD). Despite null results from recent large omega-3 FA supplementation trials, new research continues to support past studies showing that blood levels of EPA + DHA are inversely related to risk for total mortality and fatal CVD events. But blood levels of other FAs may also be useful markers of risk for a variety of diseases. The essential omega-6 FA linoleic acid is inversely associated with risk for developing type 2 diabetes (T2D), whereas risk for T2D is directly related to biomarkers of de novo lipogenesis (palmitic and palmitoleic acids). Levels of industrially produced trans FAs have been linked to higher risk for CVD. Thus, blood levels of several individual FAs are emerging as modifiable biomarkers for risk of major chronic diseases.
PURPOSE OF REVIEW: Fatty acid (FA) profiles in different blood compartments are reflections of both diet and metabolism, and some FA levels are related to disease risk. RECENT FINDINGS: Perhaps the most studied FA-disease relationship is between long-chain omega-3 polyunsaturated fatty acids [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] and cardiovascular disease (CVD). Despite null results from recent large omega-3 FA supplementation trials, new research continues to support past studies showing that blood levels of EPA + DHA are inversely related to risk for total mortality and fatal CVD events. But blood levels of other FAs may also be useful markers of risk for a variety of diseases. The essential omega-6 FAlinoleic acid is inversely associated with risk for developing type 2 diabetes (T2D), whereas risk for T2D is directly related to biomarkers of de novo lipogenesis (palmitic and palmitoleic acids). Levels of industrially produced trans FAs have been linked to higher risk for CVD. Thus, blood levels of several individual FAs are emerging as modifiable biomarkers for risk of major chronic diseases.
Authors: Jason H Y Wu; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Bruce M Psaty; David S Siscovick; Dariush Mozaffarian Journal: Circulation Date: 2014-08-14 Impact factor: 29.690
Authors: William S Harris; James V Pottala; Ramachandran S Vasan; Martin G Larson; Sander J Robins Journal: J Nutr Date: 2012-05-23 Impact factor: 4.798
Authors: Rozenn N Lemaitre; Amanda M Fretts; Colleen M Sitlani; Mary L Biggs; Kenneth Mukamal; Irena B King; Xiaoling Song; Luc Djoussé; David S Siscovick; Barbara McKnight; Nona Sotoodehnia; Jorge R Kizer; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2015-03-18 Impact factor: 7.045
Authors: Graciela E Delgado; Winfried März; Stefan Lorkowski; Clemens von Schacky; Marcus E Kleber Journal: J Clin Lipidol Date: 2017-06-01 Impact factor: 4.766
Authors: Fumiaki Imamura; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Alice H Lichtenstein; Nirupa R Matthan; David M Herrington; David S Siscovick; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2012-10-24 Impact factor: 7.045